The impact of expanded access programs for systemic anticancer therapy in an Irish cancer centre.

Background: Expanded access programs (EAPs) allow cancer patients with unmet clinical need to obtain access to pre-authorisation treatments. There is no standardised process for implementing these programs nationally, and real-world data on their impact is lacking.

Aims: This study aimed to evaluate the prevalence of such EAPs and their impact in a cancer centre.